Method for the therapeutic management of endometriosis
    1.
    发明授权
    Method for the therapeutic management of endometriosis 失效
    子宫内膜异位症治疗方法

    公开(公告)号:US07666836B2

    公开(公告)日:2010-02-23

    申请号:US11311363

    申请日:2005-12-20

    摘要: The present inventions provides a method for therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction by short term induction treatment with an LH-RH antagonist for 4 to 12 weeks. According to another aspect of the present invention, the short term LH-RH treatment is followed by the combined or separate administration of one or more active agents selected from the group consisting of a contraceptive, preferably an oral contraceptive, a non-steroidal anti-rheumatic agent, an analgetic, an androgen other than a 17-alpha-alkyl substituted testosterone or any combinations thereof. According to a further aspect of the present invention a pharmaceutical composition comprising an LHRH antagonist and one ore more active agents selected from the group consisting of a contraceptive, preferably an oral contraceptive, a non-steroidal anti-rheumatic agent, an analgetic, an androgen other than a 17-alpha-alkyl substituted testosterone or any combinations thereof are provided.

    摘要翻译: 本发明提供了一种通过LH-RH拮抗剂短期诱导治疗4至12周来治疗子宫内膜组织宫外增生,慢性盆腔疼痛和输卵管阻塞的方法。 根据本发明的另一方面,短期LH-RH治疗之后是联合或分开施用一种或多种活性剂,所述活性剂选自避孕药,优选口服避孕药,非类固醇抗生素, 风湿药,止痛剂,除17-α-烷基取代的睾酮以外的雄激素或其任何组合。 根据本发明的另一方面,包含LHRH拮抗剂和一种或多种选自避孕药,优选口服避孕药,非甾体抗风湿药,止痛剂,雄激素的活性剂的药物组合物 提供除17-α-烷基取代的睾酮或其任何组合以外的物质。

    METHOD FOR THE THERAPEUTIC MANAGEMENT OF ENDOMETRIOSIS
    2.
    发明申请
    METHOD FOR THE THERAPEUTIC MANAGEMENT OF ENDOMETRIOSIS 审中-公开
    内分泌治疗方法

    公开(公告)号:US20080255053A1

    公开(公告)日:2008-10-16

    申请号:US12099091

    申请日:2008-04-07

    IPC分类号: A61K38/08

    摘要: The present inventions provides a method for therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction by short term induction treatment with an LH-RH antagonist for 4 to 12 weeks. According to another aspect of the present invention, the short term LH-RH treatment is followed by the combined or separate administration of one or more active agents selected from the group consisting of a contraceptive, preferably an oral contraceptive, a non-steroidal anti-rheumatic agent, an analgetic, an androgen other than a 17-alpha-alkyl substituted testosterone or any combinations thereof. According to a further aspect of the present invention a pharmaceutical composition comprising an LHRH antagonist and one ore more active agents selected from the group consisting of a contraceptive, preferably an oral contraceptive, a non-steroidal anti-rheumatic agent, an analgetic, an androgen other than a 17-alpha-alkyl substituted testosterone or any combinations thereof are provided.

    摘要翻译: 本发明提供了一种通过LH-RH拮抗剂短期诱导治疗4至12周来治疗子宫内膜组织宫外增生,慢性盆腔疼痛和输卵管阻塞的方法。 根据本发明的另一方面,短期LH-RH治疗之后是联合或分开施用一种或多种活性剂,所述活性剂选自避孕药,优选口服避孕药,非类固醇抗生素, 风湿药,止痛剂,除17-α-烷基取代的睾酮以外的雄激素或其任何组合。 根据本发明的另一方面,包含LHRH拮抗剂和一种或多种选自避孕药,优选口服避孕药,非甾体抗风湿药,止痛剂,雄激素的活性剂的药物组合物 提供除17-α-烷基取代的睾酮或其任何组合以外的物质。